cobalt has been researched along with Leukemia, Lymphocytic, T Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chattopadhyay, S; Das, B; Das, D; Dash, SK; Ghosh, T; Kar Mahapatra, S; Pramanik, P; Roy, S; Tripathy, S | 1 |
1 other study(ies) available for cobalt and Leukemia, Lymphocytic, T Cell
Article | Year |
---|---|
Chitosan-modified cobalt oxide nanoparticles stimulate TNF-α-mediated apoptosis in human leukemic cells.
Topics: Apoptosis; Chitosan; Cobalt; Dose-Response Relationship, Drug; Humans; Jurkat Cells; Leukemia, T-Cell; Lymphocytes; Metal Nanoparticles; Oxides; Tumor Necrosis Factor-alpha; X-Ray Diffraction | 2014 |